[1]
M. Mazurek, E. Białowąs, E. Dybała, I. Cuber, and A. Aghadi, “Glucagon-like peptide-1 (GLP-1) agonists in the treatment of obesity”, J Educ Health Sport, vol. 13, no. 4, pp. 196–205, Feb. 2023.